Author : Naheed Ali
Publisher : Rowman & Littlefield Publishers
Page : 0 pages
File Size : 18,7 MB
Release : 2018
Category : HEALTH & FITNESS
ISBN : 9781538117248
Hepatitis afflicts many people and is a growing cause for concern. Naheed Ali, MD, breaks down the history, causes, symptoms, and treatment of hepatitis so readers, both patients and those who love them, can better understand the disease and address the needs of the sufferer from a whole person perspective.
Author : James L. Achord
Publisher : Univ. Press of Mississippi
Page : 147 pages
File Size : 10,84 MB
Release : 2002
Category : Health & Fitness
ISBN : 160473034X
Hepatitis, or inflammation of the liver, has many causes, including several viruses, a host of chemicals and drugs, bacteria, diseases of the immune system, inherited factors, and herbs. For most of the population hepatitis refers to a disease caused by viruses, and viral hepatitis is the major concern of this book. However many of the nonviral types also are mentioned. Every year, about 140,000 new cases of hepatitis A occur in the United States, and perhaps over a million around the world. Because some who are infected do not become ill, the statistics are perhaps ten times greater than the number recognized. Fortunately, this strain is not chronic (defined as disease that lasts longer than six months). Hepatitis B infects about 1,250,000 in the U.S. and about 350,000,000 worldwide. Hepatitis C, unique in many ways and virtually always chronic, has produced some 4,000,000 cases in the U.S. About 1.6 percent of the population has been infected at some time, and at least seventy-five percent in this group retain the live virus in their blood. A fourth virus, hepatitis D, is uncommon in the United States. Because viral hepatitis sometimes has serious acute and chronic consequences, reference to it often tends to raise unreasonable fears of death or disability. However, the majority who become infected suffer few complications or long-term effects. The infection rate has decreased dramatically in recent years. In comprehensible terms Understanding Hepatitis furnishes the reader with a better grasp of the disease. Featured in this book are a historical overview, a discussion of symptoms and treatment, and a report on current research. This information not only debunks fearful myths but also provides helpful particulars on how to avoid the risks for contracting hepatitis. James L. Achord, a professor emeritus at the University of Mississippi Medical Center, has published articles in such publications as Conn's Current Therapy, Gastroenterology and Hepatology: Pearls of Wisdom, and Clinical Medicine .
Author : World Health Organization
Publisher : World Health Organization
Page : 32 pages
File Size : 13,19 MB
Release : 2021-07-15
Category : Medical
ISBN : 924003112X
WHO has set a global goal to eliminate HCV as a public health problem by 2030. WHO estimates that 58 million people had chronic hepatitis C virus (HCV) infection globally in 2019, and less than a quarter of them were diagnosed. New and innovative approaches are needed to accelerate progress toward the HCV elimination targets. Self-testing is one such approach. These guidelines provide a new recommendation and guidance on HCV self-testing to complement existing HCV testing services in countries. These guidelines also highlight operational considerations to support strategic implementation and scale up of HCV self-testing.
Author : Institute of Medicine
Publisher : National Academies Press
Page : 252 pages
File Size : 34,12 MB
Release : 2010-04-23
Category : Medical
ISBN : 0309153689
The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations.
Author : World Health Organization
Publisher : World Health Organization
Page : 0 pages
File Size : 28,72 MB
Release : 2017
Category : Medical
ISBN : 9789241549981
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviors and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination. These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.
Author : Naheed Ali
Publisher : Rowman & Littlefield
Page : 193 pages
File Size : 12,60 MB
Release : 2018-11-23
Category : Health & Fitness
ISBN : 1538117258
Hepatitis can afflict anyone and can present in a variety of types. Understanding Hepatitis offers readers an overview of cutting-edge information that will help them to successfully confront this disease. Naheed Ali offers an introduction to the many forms of the disease, its causes and symptoms, its treatment and outcomes, and its risk factors. Looking at the disease from a whole-patient perspective, he details ways in which sufferers and their families can better cope with it. Since hepatitis is a life changer for anyone dealing with it, this book is a must-have addition to any public or personal library.
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 187 pages
File Size : 33,9 MB
Release : 2016-06-01
Category : Medical
ISBN : 0309438020
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.
Author : Terry May
Publisher : American Medical Publishers
Page : 250 pages
File Size : 39,84 MB
Release : 2021-11-16
Category : Medical
ISBN : 9781639271993
The inflammation of the liver tissues is known as hepatitis. The most common symptoms of hepatitis include poor appetite, vomiting, diarrhea, abdominal pain, tiredness and yellow discoloration of the skin. There are five main kinds of hepatitis- type A, B, C, D and E. Contaminated food and water spread Hepatitis A and E. Hepatitis B and C are transmitted through needle sharing by intravenous drug users. Hepatitis D infects people who are previously infected by Hepatitis B. Hepatitis is majorly caused by viruses. Heavy intake of alcohol, certain medications and toxins can also cause hepatitis. Acute hepatitis resolves on its own while the chronic form of hepatitis causes liver failure, liver cancer and scarring of the liver. This book contains some path-breaking studies. It presents researches and studies performed by experts across the globe. For all readers who are interested in hepatitis, the case studies included in this book will serve as an excellent guide to develop a comprehensive understanding.
Author : Anatomical Chart Company Staff
Publisher : Anatomical Chart Company
Page : pages
File Size : 27,98 MB
Release : 2001-01-01
Category :
ISBN : 9781587794193
Author : Kirti Shetty
Publisher : Springer Science & Business Media
Page : 501 pages
File Size : 11,56 MB
Release : 2009-06-13
Category : Medical
ISBN : 1597455652
Chronic viral hepatitis affect hundreds of millions of people worldwide, and each year millions more people become infected. In Chronic Viral Hepatitis, Second Edition, a panel of distinguished clinicians and clinical investigators build upon the first edition by comprehensively reviewing all the relevant new information regarding resistance, side effects, and therapies for chronic viral hepatitis. The text covers recent advances in the understanding of pathogenesis of viral hepatitis while discussing promising agents in development for its treatment. The authors devote special attention to reactivation of hepatitis B with chemotherapy and immunosuppression, herbal and non-traditional therapies, chronic viral hepatitis in the pediatric population, and immunology and immunotherapy of HCV and provide relative costs for all diagnostic and therapeutic options. Authoritative and up-to-date, Chronic Viral Hepatitis, Second Edition offers today's gastroenterologists, internists, hepatologists, and infectious disease specialists a practical guide to the recognition, diagnosis and treatment of chronic viral hepatitis from a multidisciplinary approach.
